Literature DB >> 12563024

Leptin constrains phospholipase C-protein kinase C-induced insulin secretion via a phosphatidylinositol 3-kinase-dependent pathway.

Joo-Won Lee1, Andrew G Swick, Dale R Romsos.   

Abstract

Leptin-deficient Lep(ob)/Lep(ob)mice hypersecrete insulin in response to acetylcholine stimulation of the phospholipase C-protein kinase C (PLC-PKC) pathway, and leptin constrains this hypersecretion. Leptin has been reported to activate phosphatidylinositol 3-kinase (PI 3-K) and subsequently phosphodiesterase (PDE) to impair protein kinase A (PKA)-induced insulin secretion from cultured islets of neonatal rats. We determined if PKA-induced insulin secretion was also hyperresponsive in islets from Lep(ob)/Lep(ob)mice, and if leptin impaired this pathway in islets from these mice. Additionally, the possible role for PI 3-K and PDE in leptin-induced control of acetylcholine-induced insulin secretion was examined. Stimulation of insulin secretion with GLP-1, forskolin (an activator of adenylyl cyclase), or IBMX (an inhibitor of PDE) did not cause hypersecretion of insulin from islets of young Lep(ob)/Lep(ob)mice, and leptin did not inhibit GLP-1-induced insulin secretion from islets of these mice. Inhibition of PDE with IBMX also did not block leptin-induced inhibition of acetylcholine-mediated insulin secretion from islets of Lep(ob)/Lep(ob)mice. But, preincubation of islets with wortmannin, an inhibitor of PI 3-K activity, blocked the ability of leptin to constrain acetylcholine-induced insulin secretion from islets of Lep(ob)/Lep(ob)mice. We conclude that the capacity of the PKA pathway to stimulate insulin secretion is not increased in islets from young Lep(ob)/Lep(ob)mice, and that leptin does not regulate this pathway in islets from mice. Leptin may stimulate PI 3-K to constrain PLC-PKC-induced insulin secretion from islets of Lep(ob)/Lep(ob)mice.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12563024     DOI: 10.1177/153537020322800207

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  8 in total

Review 1.  Obesity, Oxidative Stress, Adipose Tissue Dysfunction, and the Associated Health Risks: Causes and Therapeutic Strategies.

Authors:  Prasenjit Manna; Sushil K Jain
Journal:  Metab Syndr Relat Disord       Date:  2015-12       Impact factor: 1.894

2.  Integration of endocannabinoid and leptin signaling in an appetite-related neural circuit.

Authors:  Young-Hwan Jo; Ying-Jiun J Chen; Streamson C Chua; David A Talmage; Lorna W Role
Journal:  Neuron       Date:  2005-12-22       Impact factor: 17.173

3.  Protein kinase Cβ deficiency attenuates obesity syndrome of ob/ob mice by promoting white adipose tissue remodeling.

Authors:  Wei Huang; Rishipal R Bansode; Naresh C Bal; Madhu Mehta; Kamal D Mehta
Journal:  J Lipid Res       Date:  2011-12-30       Impact factor: 5.922

4.  Adiponectin and leptin gene polymorphisms in women with gestational diabetes mellitus.

Authors:  Andrzej Pawlik; Joanna Teler; Agnieszka Maciejewska; Marek Sawczuk; Krzysztof Safranow; Violetta Dziedziejko
Journal:  J Assist Reprod Genet       Date:  2017-01-03       Impact factor: 3.412

Review 5.  The Role of HIV Infection in the Pathophysiology of Gestational Diabetes Mellitus and Hypertensive Disorders of Pregnancy.

Authors:  Wendy N Phoswa
Journal:  Front Cardiovasc Med       Date:  2021-05-12

Review 6.  The role of leptin in glucose homeostasis.

Authors:  Heather C Denroche; Frank K Huynh; Timothy J Kieffer
Journal:  J Diabetes Investig       Date:  2012-03-28       Impact factor: 4.232

7.  Interstitial Leydig Cell Tumorigenesis-Leptin and Adiponectin Signaling in Relation to Aromatase Expression in the Human Testis.

Authors:  Michal Duliban; Ewelina Gorowska-Wojtowicz; Waclaw Tworzydlo; Agnieszka Rak; Malgorzata Brzoskwinia; Izabella Krakowska; Jan K Wolski; Malgorzata Kotula-Balak; Bartosz J Płachno; Barbara Bilinska
Journal:  Int J Mol Sci       Date:  2020-05-21       Impact factor: 5.923

8.  Serum leptin and serum leptin/serum leptin receptor ratio imbalance in obese rheumatoid arthritis patients positive for anti-cyclic citrullinated peptide antibodies.

Authors:  Eduardo Gómez-Bañuelos; Rosa Elena Navarro-Hernández; Fernanda Corona-Meraz; Perla Monserrat Madrigal-Ruíz; Beatríz Teresita Martín-Marquez; Oscar Enrique Pizano-Martinez; Jorge Aguilar-Arreola; Paul Jacob Perez-Cruz; Hector Macias-Reyes; Laura Gonzalez-Lopez; Jorge Ivan Gamez-Nava; Mario Salazar-Páramo; Monica Vazquez-del Mercado
Journal:  Arthritis Res Ther       Date:  2015-11-20       Impact factor: 5.156

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.